Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
About this item
Full title
Author / Creator
on behalf of the German Study Group of Bladder Cancer (DFBK e.V.) , German Study Group of Bladder Cancer (DFBK e.V.) , Morsch, Ronja , Rose, Michael , Maurer, Angela , Cassataro, Maria Angela , Braunschweig, Till , Knüchel, Ruth , Vögeli, Thomas-Alexander , Ecke, Thorsten , Eckstein, Markus , Weyerer, Veronika , Esposito, Irene , Ackermann, Maximilian , Niegisch, Günter and Gaisa, Nadine T.
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Immune checkpoint inhibitors (ICI) are an integral part of bladder cancer therapy, however, the relevance of ICI treatment for mixed and pure squamous cell carcinoma of the bladder remains poorly studied. Therefore, we analysed the expression of programmed death-ligand 1 (PD-L1) in urothelial carcinomas with squamous differentiation (UC/SCC) and pu...
Alternative Titles
Full title
Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
Authors, Artists and Contributors
Author / Creator
German Study Group of Bladder Cancer (DFBK e.V.)
Morsch, Ronja
Rose, Michael
Maurer, Angela
Cassataro, Maria Angela
Braunschweig, Till
Knüchel, Ruth
Vögeli, Thomas-Alexander
Ecke, Thorsten
Eckstein, Markus
Weyerer, Veronika
Esposito, Irene
Ackermann, Maximilian
Niegisch, Günter
Gaisa, Nadine T.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5c348b97efc543179a1168c7a766ad9b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5c348b97efc543179a1168c7a766ad9b
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-020-06727-2
